Fund profile · Compiled from public sources

Diamond Biofund

Taipei, Taiwan · Seed → Series B

Their stated focus (public profile)

Diamond Biofund is Taiwan's first publicly listed evergreen biotech venture capital firm, specializing in biotechnology and medical investments. It targets globally competitive opportunities including new drug R&D, high-end medical equipment, innovative medical services and channels, and agricultural biotechnology. The fund supports portfolio companies beyond capital with expertise in corporate governance, R&D, clinical implementation, and capital market integration, with a mission to 'Nurture Innovation for Better Quality of Life.'

Stages: Seed → Series B

Sectors: Life sciences, Healthtech, Medtech

On file: 5 partners on record

Website: diamondbiofund.com

This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.

Is this your fund? Request a correction or removal.

For founders · Find a fund

Search the funds we have on file

Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.

    Looking to claim your own fund? Start here →